News

In patients with uncontrolled asthma, the need for escalation to biologics may often be attributable to suboptimal treatment adherence rather than to lack of efficacy of the maintenance therapy.
Bender B, Oppenheimer J, George M, et al. Assessment of real-world escalation to biologics in US patients with asthma. J Allergy Clin Immunol Pract. Published online August 2, 2022. doi:10.1016/j ...
Following an asthma-related hospitalization, percentages of patients who did not have specialist visits or medication escalation included 35% of Black patients, 32% of Hispanic/Latino patients, 28 ...
In patients with uncontrolled asthma, the need for escalation to biologics may often be attributable to suboptimal treatment adherence rather than to lack of efficacy of the maintenance therapy.
Escalation to Biologics in Asthma: The Role of Suboptimal Treatment Adherence. Ron Goldberg | March 9, 2022 . multiple inhalers on a white background ...